![創新藥物的商業成功之路 - 從實驗室到上市](/upload/activity/activity_20240712111238_0.jpg)
創新藥物的商業成功之路 - 從實驗室到上市
Session 10 – Translational Medicine, A Journey from Novelty to Commercial Success
- 日 期:2024-07-25
- 地 點:台北南港展覽館二館7樓Room 700
- 主辦單位:國家衛生研究院
活動介紹
![](/upload/article/_images/S__71295186.jpg)
活動議程
16:00 – 16:05
16:05 – 16:25
16:25 – 16:45
16:45 – 17:05
17:05 – 17:30
Opening Remarks
16:05 – 16:25
Understanding Protein Dynamics for Structure-based Drug Design: Design Stories of Crizotinib, Lorlatinib and Repotrectinib
Jingrong Jean Cui, President & CEO, BlossomHill Therapeutics, Inc.16:25 – 16:45
Bozitinib: from Bench to Bedside
Boyu Zhong, President, CSO, Tyligand Bioscience Ltd.16:45 – 17:05
Translation Medicine from CMC perspectives, from Preclinical to Commercial
David Chang, Ph.D., CEO, Taiwan Bio-Manufacturing Corporation (TBMC)17:05 – 17:30
Panel Discussion
Moderator:
Hsing-Pang Hsieh, Director, National Health Research Institutes, Institute of Biotechnology and Pharmaceutical Research (IBPR)
Panelists: